Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme. - Wikidata - awgldk - TriplyDB

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

http://www.wikidata.org/entity/Q33346613

about

Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO)

P2860

Q36500411-9B564D25-32FC-435C-8FA6-5F1E024744F4

P2860

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

http://www.wikidata.org/entity/Q33346613

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@ast

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@en

type

label

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@ast

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@en

prefLabel

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@ast

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@en

P1433

Q33346613-B4BC2DBD-8F5E-4DD8-8B5C-3BF7CB91A866

P1476

Q33346613-DC543370-E531-4743-A649-EC4C812EDAC7

P2093

Q33346613-182B83DD-E81E-44F7-B25F-35043920ED74

Q33346613-25B1B795-FF01-456F-B303-CCE6B1D6DC49

Q33346613-68603A0D-7C9E-4E48-9E60-A92601A136BD

Q33346613-77152643-C8C3-4EE7-AFF3-A960824ADF77

Q33346613-7AAAEFB0-ED2D-4B23-B17C-11C3AA44954F

Q33346613-986A1301-A627-446E-B156-1F7E24F557A2

Q33346613-A8CE1F42-6151-4097-925D-B17CE925C061

Q33346613-D652C817-BD85-4C2C-ABB6-BAB6529C929C

Q33346613-EDF3E467-7531-4416-BD82-75D3D721F0C3

P2860

Q33346613-0048DAEB-0774-4B27-89BC-599873C6B74B

Q33346613-0B70CD47-DB97-4DAC-A18F-D929B8CB64B4

Q33346613-0CB9888E-60A2-4F78-BB9A-527CCEFF825B

Q33346613-15F70632-D0F3-44E3-A35E-6237EDD188F8

Q33346613-1655B3BA-CF82-4C95-8D44-088D5923EEF1

Q33346613-1F0EC0CE-DCB0-4938-86FE-95F2957AB442

Q33346613-2F363B05-84F5-4704-819E-CA31F1845DE7

Q33346613-34238B24-4B6A-4887-8006-6F7A2BC22868

Q33346613-3BBDEFA3-FD9C-45B7-A2F3-0398A7EE91B1

Q33346613-3BC7FCE6-C6F4-4098-9566-9300E432EE0E

P2888

Q33346613-FEA8650C-98C3-459E-A7E0-2DF4019CDC2B

P304

Q33346613-BD4AE4EB-E2CC-4A5D-A72E-0E830D04A706

P31

Q33346613-FDD6DE6C-15BE-4047-9C34-0143E09E2F08

P356

Q33346613-230DFB50-3D53-432B-B37C-FCEBA0E611A9

P407

Q33346613-15224EC4-3C28-4B1C-8DD0-75EAA3362F6B

P433

Q33346613-C56BA766-3AD9-453F-A80A-76AC200A6506

P478

Q33346613-CA096C6C-3A66-4843-968A-BD735BDE76ED

P577

Q33346613-E0F8A4AE-FF4B-463D-A355-E1920F3BEEDB

P5875

Q33346613-1E6E8692-6A95-4DC6-8736-2C2DF70DAA9F

P6179

Q33346613-9BF8020A-0A4D-4142-A86F-3E09FA593E97

P698

Q33346613-C2B53CDE-B7C7-46CA-A013-2EF66E9717AA

P932

Q33346613-1FCD5C46-B856-4DC8-ACDD-783D44A4D2DD

P356

P1433

British Journal of Cancer

P1476

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

@en

P2093

B Fazeny-Dörner

http://www.w3.org/2001/XMLSchema#string

C Marosi

http://www.w3.org/2001/XMLSchema#string

C Wenzel

http://www.w3.org/2001/XMLSchema#string

J Hainfellner

http://www.w3.org/2001/XMLSchema#string

K Dieckmann

http://www.w3.org/2001/XMLSchema#string

K Rössler

http://www.w3.org/2001/XMLSchema#string

K Ungersböck

http://www.w3.org/2001/XMLSchema#string

M Piribauer

http://www.w3.org/2001/XMLSchema#string

M Veitl

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of temozolomide (CCRG 81045: M&B; 39831: NSC 362856)

Nonparametric Estimation from Incomplete Observations

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme.

Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicity.

Phase II study of fotemustine in recurrent supratentorial malignant gliomas.

Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group.

Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

P2888

P304

496-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600769

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10896019

http://www.w3.org/2001/XMLSchema#string

P6179

1018290149

http://www.w3.org/2001/XMLSchema#string

P698

12592361

http://www.w3.org/2001/XMLSchema#string

P932

2377158

http://www.w3.org/2001/XMLSchema#string